Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
From MaRDI portal
Publication:1670482
DOI10.1007/s11538-018-0424-4zbMath1396.92032arXiv1911.12876OpenAlexW2799686795WikidataQ52592597 ScholiaQ52592597MaRDI QIDQ1670482
Adelle C. F. Coster, Chae-Ok Yun, Peter S. Kim, Adrianne L. Jenner
Publication date: 5 September 2018
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1911.12876
Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)
Related Items
A mathematical model for tumor growth and treatment using virotherapy, Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy, Slow-fast model and therapy optimization for oncolytic treatment of tumors, Stability analysis of a fractional virotherapy model for cancer treatment, On a mathematical model of tumor-immune system interactions with an oncolytic virus therapy, On the treatment of melanoma: a mathematical model of oncolytic virotherapy, Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy, Population dynamics with threshold effects give rise to a diverse family of allee effects, Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses, Oscillation thresholds via the novel MBR method with application to oncolytic virotherapy, Spatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems, A fractional mathematical model of breast cancer competition model, Modelling heterogeneity in viral-tumour dynamics: the effects of gene-attenuation on viral characteristics, Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections, Hopf bifurcation analysis of a tumor virotherapy model with two time delays, Modeling the virus-induced tumor-specific immune response with delay in tumor virotherapy, Oncolytic virotherapy for tumours following a Gompertz growth law, A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept, Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model
Cites Work
